Table 1.
Patient characteristics at baseline
| Patient no. | Sex | Age, yr | BMI, kg/m2 | Cirrhosis (Child-Pugh score) | Initial HCV RNA level, log10 IU/mL | Previous anti-HCV treatment and response |
|---|---|---|---|---|---|---|
| 1 | M | 58 | 24.3 | No | 6.40 | Naive |
| 2 | M | 27 | 17.8 | No | 3.33 | Naive |
| 3 | F | 65 | 25.9 | No | 5.29 | Naive |
| 4 | M | 54 | 18.1 | Yes (A6) | 6.35 | PEG+RBV, relapse |
| 5 | M | 66 | 22.2 | No | 5.89 | Naive |
| 6 | F | 69 | 16.2 | No | 6.69 | Naive |
| 7 | M | 62 | 27.1 | No | 2.96 | Naive |
| 8 | F | 82 | 19.5 | No | 7.18 | Naive |
| 9 | M | 56 | 22.1 | Yes (A6) | 6.72 | PEG+RBV, relapse |
BMI, body mass index; HCV, hepatitis C virus; RNA, ribonucleic acid; PEG, pegylated interferon; RBV, ribavirin.